Carlsmed (CARL) Stock Analysis & Winston Score

Carlsmed is a medical technology company that makes personalized surgical implants for spine surgery. It uses software and data to design custom hardware — like rods and spacers — that fit each patient's unique spine, rather than using standard off-the-shelf parts. Surgeons at hospitals across the United States are the main customers. The company earns money by selling these custom implants directly to hospitals and surgical centers on a per-procedure basis. It operates primarily in the U.S. spine surgery market, which is large but competitive, with established players like Medtronic and Zimmer Biomet. Carlsmed's edge is its software-driven personalization platform, which makes switching to a competitor harder once a surgeon adopts the workflow. However, the company is currently losing money — its operating margin is deeply negative — so the key risk is whether it can grow revenue fast enough to reach profitability before needing to raise additional capital.